RNA sequencing reveals induction of specific renal inflammatory pathways in a rat model of malignant hypertension.

Abstract

In malignant hypertension, far more severe kidney injury occurs than in the "benign" form of the disease. The role of high blood pressure and the renin-angiotensin-aldosterone system is well recognized, but the pathogenesis of the renal injury of malignant hypertension (MH) remains incompletely understood. Using the rat model of two-kidney, one-clip renovascular hypertension in which some but not all animals develop MH, we performed a transcriptomic analysis of gene expression by RNA sequencing to identify transcriptional changes in the kidney cortex specific for MH. Differential gene expression was assessed in three groups: MH, non-malignant hypertension (NMH), and normotensive, sham-operated controls. To distinguish MH from NMH, we considered two factors: weight loss and typical renovascular lesions. Mean blood pressure measured intraarterially was elevated in MH (220 ± 6.5 mmHg) as well as in NMH (192 ± 6.4 mmHg), compared to controls (119 ± 1.7 mmHg, p < 0.05). Eight hundred eighty-six genes were exclusively regulated in MH only. Principal component analysis revealed a separated clustering of the three groups. The data pointed to an upregulation of many inflammatory mechanisms in MH including pathways which previously attracted relatively little attention in the setting of hypertensive kidney injury: Transcripts from all three complement activation pathways were upregulated in MH compared to NMH but not in NMH compared with controls; immunohistochemistry confirmed complement deposition in MH exclusively. The expression of chemokines attracting neutrophil granulocytes (CXCL6) and infiltration of myeloperoxidase-positive cells were increased only in MH rats. The data suggest that these pathways, especially complement deposition, may contribute to kidney injury under MH. KEY MESSAGES: The most severe hypertension-induced kidney injury occurs in malignant hypertension. In a rat model of malignant hypertension, we assessed transcriptional responses in the kidney exposed to high blood pressure. A broad stimulation of inflammatory mechanisms was observed, but a few specific pathways were activated only in the malignant form of the disease, notably activation of the complement cascades. Complement inhibitors may alleviate the thrombotic microangiopathy of malignant hypertension even in the absence of primary complement abnormalities.

• Authors: Carlos Menendez-Castro, Nada Cordasic, Fabian B Fahlbusch, Arif B Ekici, Philipp Kirchner, Christoph Daniel, Kerstin Amann, Roland Velkeen, Joachim Wölfle, Mario Schiffer, Andrea Hartner, Karl F Hilgers
• Journal: Journal of molecular medicine (Berlin, Germany) (J Mol Med (Berl)) Vol. 99 Issue 12 Pg. 1727-1740 (12 2021) ISSN: 1432-1440 [Electronic] Germany
• PMID: 34528115 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2021. The Author(s).

Chemical References

• Complement System Proteins

Topics

• Animals
• Complement System Proteins (metabolism)
• Hypertension, Malignant (genetics, metabolism)
• Hypertension, Renovascular (genetics, metabolism)
• Kidney (metabolism)
• Male
• Rats, Sprague-Dawley
• Sequence Analysis, RNA
• Rats